While low levels of NRF2 can prevent tumor initiation by promoting cell survival under stress, high levels may enable cancer cells to thrive and proliferate by conferring resistance to chemo-therapeutic agents [42]. The gene discussed is NFE2L2; the disease is neoplasm.